Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    20010070 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
2 Completed
Has Results
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
Condition: HIV-1 Infection
Intervention: Drug: Atazanavir/ritonavir monotherapy
3 Recruiting Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients
Condition: HIV
Interventions: Drug: dolutegravir 50mg +abacavir 600mg +lamivudine 300mg;   Drug: dolutegravir
4 Active, not recruiting Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
Condition: HIV Infection
Interventions: Drug: monoPI - boosted lopinavir or boosted darunavir;   Drug: bi therapy - (boosted lopinavir or boosted darunavir) + lamivudine

Study has passed its completion date and status has not been verified in more than two years.